Nuwill Competitors and Similar CompaniesClear all
Nuwill's competitors and similar companies include Shanghai Shenqi Pharmaceutical, Laurus Labs, Ergomed and GSK.
 Shanghai Shenqi Pharmaceutical Shenqi Pharmaceutical (also known as Shanghai Shenqi Pharmaceutical Investment Management, 神奇制药投资管理股份有限公司) is a pharmaceutical holding company specialized in the research, manufacturing, and distribution of medicine. |  Ergomed Ergomed Group is a company that provides drug development services to the pharmaceutical industry. |  GSK GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. | |||
Founding Date | Founding Date 2010 | Founding Date 1983 | Founding Date 2005 | Founding Date 1997 | Founding Date 2000 |
Type | Type Private | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Bengaluru, IN HQ | Locations Shanghai, CN HQ | Locations Hyderabad, IN HQ Hamburg, DE Turkapally, IN Visakhapatnam, IN Visakhapatnam, IN Visakhapatnam, IN Visakhapatnam, IN see more | Locations Guildford, GB HQ | Locations London, GB HQ Boumerdes, DZ Buenos Aires, AR Abbotsford, AU Wien, AT Wavre, BE Rio De Janeiro, BR see more |
Employees | Employees 603% increase | Employees 1,26611% decrease | Employees 5,75359% increase | Employees 1,800 | Employees 68,629 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 571.4 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 862.5 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥2b (FY, 2024) | Revenue (est.) ₹68.1b (FY, 2026) | Revenue (est.) £145.3m (FY, 2022) | Revenue (est.) £32.7b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ¥1.1b (FY, 2024) | Cost of goods ₹27b (FY, 2026) | Cost of goods £86.1m (FY, 2022) | Cost of goods £5.6b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit ¥946.8m (FY, 2024) | Gross profit ₹41.7b (FY, 2026) | Gross profit £60.3m (FY, 2022) | Gross profit £28.5b (FY, 2025) |
Net income | Net income N/A | Net income ¥66.1m (FY, 2024) | Net income ₹8.9b (FY, 2026) | Net income £15m (FY, 2022) | Net income £6.3b (FY, 2025) |
Operating ⚠ | |||||
Countries | Countries N/A | Countries N/A | Countries N/A | Countries 140 (FY, 2021) | Countries 92 (FY, 2021) |
For sources of this data, please see the company profile
View Company Profiles
Shanghai Shenqi Pharmaceutical
HQ
Shanghai, CN
Employees
1,266↓ 11% decrease
Shenqi Pharmaceutical (also known as Shanghai Shenqi Pharmaceutical Investment Management, 神奇制药投资管理股份有限公司) is a pharmaceutical holding company specialized in the research, manufacturing, and distribution of medicine.
View companyErgomed
HQ
Guildford, GB
Employees
1,800
Ergomed Group is a company that provides drug development services to the pharmaceutical industry.
View companyGSK
HQ
London, GB
Employees
68,629
GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products.
View company